Skip to main content

Beneficial ownership — 13D / 13G

87,339 recent Schedule 13D / 13G filings — activist (13D) and passive (13G) stakes above 5% of a class.

Reporting person Issuer Schedule % of class Filed
BlackRock Inc. AAXJ iShares Trust 13G 33.3% 2y
BlackRock Inc. TDW Tidewater Inc 13G/A 12.5% 2y
BlackRock Inc. ATRA Atara Biotherapeutics, Inc. 13G/A 0% 2y
BlackRock Inc. KZR Kezar Life Sciences, Inc. 13G/A 1.1% 2y
BlackRock Inc. BCLO BlackRock ETF Trust II 13G 50% 2y
BlackRock Inc. VCYT Veracyte, Inc. 13G/A 10.2% 2y
BlackRock Inc. SVCO Silvaco Group, Inc. 13G/A 2.7% 2y
BlackRock Inc. CSTL Castle Biosciences Inc 13G/A 11% 2y
BlackRock Inc. CNTY Century Casinos Inc 13G/A 1.8% 2y
BlackRock Inc. ACRS Aclaris Therapeutics, Inc. 13G/A 2.9% 2y
BlackRock Inc. ELAN Elanco Animal Health Inc 13G/A 4.7% 2y
BlackRock Inc. NDLS NOODLES & Co 13G/A 1.3% 2y
BlackRock Inc. CVNA Carvana Co. 13G/A 4.2% 2y
BlackRock Inc. HE Hawaiian Electric Industries Inc 13G/A 10.2% 2y
BlackRock Inc. STOK Stoke Therapeutics, Inc. 13G 10.4% 2y
BlackRock Inc. AAXJ iShares Trust 13G/A 19.5% 2y
BlackRock Inc. TTEC TTEC Holdings, Inc. 13G/A 3.7% 2y
WELLINGTON MANAGEMENT GROUP LLP TPG TPG Inc. 13G 10.16% 2y
SR One Capital Management, LLC KALA KALA BIO, Inc. 13D 9.99% 2y
WELLINGTON MANAGEMENT GROUP LLP CUBI Customers Bancorp, Inc. 13G/A 10.18% 2y
Bryan Sheffield TBN Tamboran Resources Corp 13D 16.1% 2y
WELLINGTON MANAGEMENT GROUP LLP SDHC Smith Douglas Homes Corp. 13G 12.53% 2y
WESTFIELD CAPITAL MANAGEMENT CO LP MURA Mural Oncology plc Ordinary Shares 13G/A 4.39% 2y
RA CAPITAL MANAGEMENT, L.P. RXRX Recursion Pharmaceuticals, Inc. 13G 5.9% 2y
John Fichthorn DMAC DiaMedica Therapeutics Inc. 13G 5.2% 2y
WELLINGTON MANAGEMENT GROUP LLP MFA Mfa Financial, Inc. 13G/A 10.67% 2y
WELLINGTON MANAGEMENT GROUP LLP RWT Redwood Trust Inc 13G/A 10.34% 2y
WELLINGTON MANAGEMENT GROUP LLP MORF Morphic Holding, Inc. Common Stock 13G/A 11.61% 2y
FMR LLC NMRA Neumora Therapeutics, Inc. 13G 5.4% 2y
COATUE MANAGEMENT LLC HUT Hut 8 Corp. 13G 9.2% 2y
Kenneth R. Lehman BRBS Blue Ridge Bankshares, Inc. 13D/A 27.2% 2y
Lam Chi Ming PMA PMA Graphene Technology Group Inc. 13D 100% 2y
Liberty Energy Services LLC (f/k/a Liberty Oilfield Services LLC) TBN Tamboran Resources Corp 13G 6.3% 2y
Ayrton Capital LLC LUCD Lucid Diagnostics Inc. 13G/A 9.9% 2y
Ghisallo Capital Management LLC THCP Thunder Bridge Capital Partners IV, Inc. Class A Common Stock 13G 10.5% 2y
Artal Participations S.a r.l HOOK HOOKIPA Pharma Inc. 13G 5.9% 2y
LionGuard Capital Management Inc. ACCS ACCESS Newswire Inc. 13G/A 0% 2y
North Star Investment Management Corp. BGSF Bgsf, Inc. 13G/A 2.7% 2y
The Coca-Cola Company COKE Coca-Cola Consolidated, Inc. 13D/A 24.3% 2y
Al Shams Investments Limited BHR Braemar Hotels & Resorts Inc. 13D/A 9.8% 2y
Ronald S. Boreta AASP Agassi Sports Entertainment Corp. 13D 34.4% 2y
OPKO HEALTH, INC. WGS GeneDx Holdings Corp. 13D/A 13.27% 2y
Askew James M. AASP Agassi Sports Entertainment Corp. 13D 13.7% 2y
Timothy A. Springer RNAC Cartesian Therapeutics, Inc. 13D/A 36.3% 2y
JANUS HENDERSON GROUP PLC ORKA Oruka Therapeutics, Inc. 13G/A 10.2% 2y
Jacques Patrick Supervielle SUPV Grupo Supervielle S.A. 13G/A 4.2% 2y
BBAI Ultimate Holdings, LLC BBAI BigBear.ai Holdings, Inc. 13D/A 58% 2y
BRIGADE CAPITAL MANAGEMENT, LP GFR Greenfire Resources Ltd. 13D/A 7.8% 2y
BAILLIE GIFFORD & CO GH Guardant Health, Inc. 13G/A 4.98% 2y
BAILLIE GIFFORD & CO ALNY Alnylam Pharmaceuticals, Inc. 13G/A 4.77% 2y